Don't have an account?
See and biopsy what matters.
Serena Bright™ makes it possible to clearly target lesions enhancing with contrast spectral mammography.
Serena Bright makes it possible to clearly target lesions enhancing with contrast spectral mammography. Leverage the Pristina Serena ease of use with no additional hardware added. Easy scheduling and familiar setting for your patient vs MRI-guided biopsy.
Serena Bright makes it possible to clearly target lesions enhancing with contrast spectral mammography. Leverage the Pristina Serena ease of use with no additional hardware added. Easy scheduling and familiar setting for your patient vs MRI-guided biopsy.
Benefits
See and biopsy what matters
See the lesion in CESM and sample with certainty with the same image guidance.
Patient experience:
Patients who had breast MRI in the past, described their experience with contrast biopsy was much easier and tolerable."
Anat Kornecki, MD. Breast Radiologist
A Familiar setting:
Familiar setting & familiar staff helping to relieve some of the stress of a biopsy procedure.
Senographe Pristina ™: A better Mammography experience⁵
Pristina Serena™
DBT guided biopsy positioner helps make the inaccessible accessible. Pristina Serena 3D makes complex procedures and challenging cases faster, easier, and more accessible for clear, concise results.7,8
More information
Community
Our community is aimed at improving the quality of content shared and overall patient experience. Click here to find important resources and links.
Education
Gain the knowledge you need to operate your equipment effectively, optimize image quality and care for your patients.
Stories
Stay connected with us for our latest mammography developments – including provider and patient stories, events and more.
References
- Data on file. GE Healthcare; 2020 Time from first to last image
- Hobbs et al., Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance, J Med Imaging Radiat Oncol. 2015
- CESM Biopsy vs MR Biopsy Cost Analysis. Data on file. GE Healthcare 2020
- Data on file. GE Healthcare 2018
- IPSOS Patient Satisfaction Study sponsored by GE Healthcare conducted with 315 patients across 2 sites in Europe, February 2017
- 510(k) K172404
- Data on file. GE Healthcare 2018
- Data on File, GE Healthcare 2019
JB01060AU April 2023